$Madrigal Pharmaceuticals (MDGL.US)$ $Nuburu (BURU.US)$ $Pro-Dex (PDEX.US)$ $ASP Isotopes (ASPI.US)$ $GRI Bio (GRI.US)$ $Vast Renewables (VSTE.US)$ $MicroCloud Hologram (HOLO.US)$ $Theriva Biologics (TOVX.US)$ $Pluribus Technologies Corp (PLRB.CA)$ $Ensysce Biosciences (ENSC.US)$ $Athira (ATHA.US)$ $Globalstar (GSAT.US)$ $ChromaDex (CDXC.US)$
📊⚡️📊

$CNS Pharmaceuticals (CNSP.US)$
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance With Minimum Bid Price Requirement
til March 2025
*not financial advice

$CNS Pharmaceuticals (CNSP.US)$ just bought 150K lets gooo!

$J-Long Group (JL.US)$ Good morning ☕️🎃

$Sprouts Farmers Market (SFM.US)$ $J-Long Group (JL.US)$ $Confluent (CFLT.US)$ $Tenon Medical (TNON.US)$ $Adicet Bio (ACET.US)$ $Remitly Global (RELY.US)$ $Carvana (CVNA.US)$ $Avadel Pharmaceuticals (AVDL.US)$ $Alphatec (ATEC.US)$ $CPS Technologies (CPSH.US)$ $1847 Holdings (EFSH.US)$ $LuxUrban Hotels (LUXH.US)$ $Root Inc (ROOT.US)$
📊⚡️📊

$SRIVARU Holding (SVMH.US)$ fire sale

$SRIVARU Holding (SVMH.US)$
SVMH (SRIVARU Holding) shows high speculative potential, with a current oversold level indicating a possible short-term rebound. At $0.028, the stock is heavily discounted, with strong support at $0.026. If it holds, there’s significant upside, aiming for a recovery towards the resistance at $0.174—a potential gain of over 500%.

$SRIVARU Holding (SVMH.US)$ what a perfect opportunity 👌